Circulating Tumor DNA (ctDNA) Sequencing

A New Generation of Cancer Biomarkers – Circulating Tumor DNA (ctDNA) Detection and Monitoring

Circulating tumor DNA (ctDNA) are fragments of DNA from dying cancer cells found in the blood of cancer patients. At Ayass BioScience, we utilize a minimally invasive method (alternative to risky and invasive tumor biopsies) that requires only a few milliliters of plasma from patients to detect mutations in genes associated with cancer. ctDNA is detectable for most types of cancer and could be used as an effective screening method and as a way to monitor the response to therapeutic treatments for most patients.

ctDNA

Genetic Testing Circulating Tumor DNA, DNA Testing, Next Generation Sequencing, NGS, Genetic Disease, Inherited Disease

NEXT GENERATION SEQUENCING – SOMATIC MUTATION

Our ctDNA panel targets 28 genes commonly found mutated in solid tumor type cancers. This assay is performed using cell free DNA isolated from human plasma specimens. The test is intended to identify the presence of circulating tumor DNA and identify mutations in genes associated with cancer. The test can be used for the monitoring of cancer remission after treatment such as chemotherapy, radiation or surgery.

ALK
CTNNB1
ESR1
IDH2
MAP2K2
NTRK3
ROS1
AKT1
DDR2
FGFR1
KIT
MET
PIK3CA
SMAD4
AR
EGFR
HRAS
KRAS
NRAS
PDGFRA
MTOR
BRAF
ERBB2 (HER2)
IDH1
MAP2K1
NTRK1
RET
TP53

If you have any questions about Circulating Tumor DNA Sequencing at Ayass BioScience, LLC,  please call today at 972-668-6005 or fill out our contact form on the bottom of this page. We will answer any question you might have.